SCHEMBL15423005

SCHEMBL15423005

[2H]C([2H])([2H])n1c(C)nc2c1c(=O)n(CCCC([2H])([2H])[C@@]([2H])(C)O)c(=O)n2C([2H])([2H])[2H]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 4/20 0.39
▸ LMNA P02545 4/20 0.34
▸ TSHR P16473 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ NFKB1 P19838 2/20 0.34
▸ ACHE P22303 2/20 0.34
▸ PDE4A P27815 2/20 0.34
▸ PMP22 Q01453 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ RAB9A P51151 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15340995 1.00 TNF (0.39) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6878443 0.98 TNF (0.41) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6878338 0.98 TNF (0.41) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6877221 0.98 TNF (0.41) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL11921637 0.94 TNF (0.38) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL11921634 0.92 TNF (0.40) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6876037 0.92 TNF (0.43) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6878530 0.92 TNF (0.43) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6878515 0.92 TNF (0.43) TNFLMNATSHRSMN1; SMN2CYP1A2
SCHEMBL6875923 0.90 TNF (0.42) TNFLMNATSHRSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9085788-B2 Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation CONCERT PHARMACEUTICALS, INC. (US) 2015-07-21 — — US disclosed
US-20140017739-A1 PROCESS FOR PREPARING AN ENANTIOMERICALLY ENRICHED, DEUTERATED SECONDARY ALCOHOL FROM A CORRESPONDING KETONE WITHOUT REDUCING DEUTERIUM INCORPORATION CONCERT PHARMACEUTICALS, INC. (US) 2014-01-16 — — US disclosed
Send feedback